Open AccessCopper-64 trastuzumab PET imaging: a reproducibility study
Author(s) -
Jorge A. Carrasquillo,
Patrick G. Morris,
John L. Humm,
Peter SmithJones,
Volkan Beylergil,
Timothy Akhurst,
Joseph A. O’Donoghue,
Shutian Ruan,
Shanu Modi,
Clifford A. Hudis,
Steven M. Larson
Publication year - 2019
Publication title -
the quarterly journal of nuclear medicine and molecular imaging
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.414
H-Index - 61
eISSN - 1827-1936
pISSN - 1824-4785
DOI - 10.23736/s1824-4785.16.02867-3
Subject(s) - trastuzumab , medicine , reproducibility , pharmacokinetics , biodistribution , nuclear medicine , adverse effect , breast cancer , cancer , in vivo , chromatography , microbiology and biotechnology , biology , chemistry
The current study aims to assess the safety, pharmacokinetics, feasibility, and reproducibility of immunoPET imaging with copper-64 (64Cu) trastuzumab.